A study indicated that after 3 months of GLP-1 receptor agonist (GLP-1Ra) treatment, obese subjects with diabetes showed improved Montreal Cognitive Assessment (MoCA) scores, higher olfactory test scores, and enhanced activation of the right parahippocampus in response to odors (Zhang et al., 2019). The gene discussed is GLP1R; the disease is diabetes mellitus.